Status:
UNKNOWN
COVID-19: Immunological Mechanisms in Multisystem Inflammatory Syndrome in Children
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Multisystem Inflammatory Syndrome in Children
COVID-19
Eligibility:
All Genders
1-17 years
Brief Summary
This study seeks to explore immunological mechanisms in patients with Multisystem Inflammatory Syndrome in Children (MIS-C) to improve the understanding of this pathogenesis of this disease. In a coh...
Detailed Description
BACKGROUND Multisystem inflammatory syndrome in children (MIS-C) is a rare severe complication to SARS-CoV-2 infection in children. Thousands of children worldwide have been hospitalized with this new...
Eligibility Criteria
Inclusion
- Patients diagnosed with MIS-C, according to the CDC criteria aged 0-17 years
Exclusion
- Patients from whom patient/parent/legal guardian signed consent is not received
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05334134
Start Date
February 1 2020
End Date
June 30 2023
Last Update
April 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ulrikka Nygaard
Copenhagen, Denmark, 2100